Two cheap and common drugs could be re-purposed as the first specific treatment for people who experience a type of stroke linked to nearly half…
Medical Humanities experts at the University of Surrey have offered important opportunities to safeguard the quality of life of people living with dementia in Medellín,…
A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment,…
University of New Mexico neurologist Rawan Tarawneh, MD, has identified a unique biomarker that could lead to new diagnostic tests to improve the detection of…
As the Alzheimer’s disease scientific community, patients, and families seek to understand the results of clinical trials of new Alzheimer’s treatments, the Alzheimer’s Association convened…
Sometimes in science, “Eureka!” moments happen with surprisingly little effort. Sometimes they take years or decades to emerge. Such was the case with Brian Kraemer’s…
JAMA Neurology has published the results of the first international population-based study on epidemiology of Frontotemporal Dementia (FTD) involving nine European countries and thirteen neurological…
More than 55 million people worldwide were living with Alzheimer’s disease in 2020, according to Alzheimer’s Disease International. This figure is expected to almost double…
Pre-existing dementia complicates cancer care and increases the risk of worse clinical outcomes and inferior patient experience, according to a review of studies exploring the…
A common sign of Alzheimer’s disease is the excessive buildup of two types of protein in the brain: tangles of tau proteins that accumulate inside…
